We are live on ! Find out more
GCM

Gladius Capital Management Portfolio holdings

AUM $2.24B
1-Year Est. Return 23.45%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+23.45%
3 Year Est. Return
+63.4%
5 Year Est. Return
+55.08%
10 Year Est. Return
+183.67%
AUM
$1.68B
AUM Growth
-$133M
Cap. Flow
-$223M
Cap. Flow %
-13.29%
Top 10 Hldgs %
66.23%
Holding
183
New
57
Increased
13
Reduced
95
Closed
16

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.4M
2
MSFT icon
Microsoft
MSFT
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.95M
4
AMZN icon
Amazon
AMZN
+$8.87M
5
C icon
Citigroup
C
+$8.77M

Sector Composition

Rank Sector Weight
1 Communication Services 2.27%
2 Technology 1.16%
3 Healthcare 0.69%
4 Consumer Discretionary 0.49%
5 Industrials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
126
CALL
Wells Fargo
WFC
$263B
$597K 0.04%
+12,500
New +$585K
C icon
127
Citigroup
C
$222B
$572K 0.03%
8,079
-131,073
-94% -$8.77M
GS icon
128
Goldman Sachs
GS
$305B
$549K 0.03%
2,652
-29,943
-92% -$5.93M
MMM icon
129
PUT
3M
MMM
$94.1B
$541K 0.03%
3,708
-19,016
-84% -$2.93M
CVX icon
130
Chevron
CVX
$374B
$537K 0.03%
4,301
-24,076
-85% -$2.91M
BA icon
131
CALL
Boeing
BA
$175B
$535K 0.03%
1,500
-48,500
-97% -$17.7M
IBM icon
132
IBM
IBM
$214B
$529K 0.03%
3,954
-6,458
-62% -$848K
C icon
133
CALL
Citigroup
C
$222B
$517K 0.03%
+7,300
New +$488K
UNP icon
134
Union Pacific
UNP
$175B
$463K 0.03%
2,697
+186
+7% +$31.9K
ABBV icon
135
AbbVie
ABBV
$465B
$460K 0.03%
6,260
-19,882
-76% -$1.56M
NFLX icon
136
CALL
Netflix
NFLX
$301B
$450K 0.03%
+12,000
New +$433K
PG icon
137
Procter & Gamble
PG
$347B
$444K 0.03%
4,016
-11,213
-74% -$1.2M
MMM icon
138
3M
MMM
$94.1B
$430K 0.03%
2,947
-3,565
-55% -$549K
AVGO icon
139
Broadcom
AVGO
$1.81T
$425K 0.03%
14,120
-6,220
-31% -$181K
PEP icon
140
PepsiCo
PEP
$195B
$421K 0.03%
3,185
-12,834
-80% -$1.65M
BKNG icon
141
Booking.com
BKNG
$154B
$397K 0.02%
5,225
-10,550
-67% -$758K
AMGN icon
142
CALL
Amgen
AMGN
$212B
$392K 0.02%
+2,100
New +$376K
TMO icon
143
CALL
Thermo Fisher Scientific
TMO
$214B
$390K 0.02%
+1,300
New +$358K
CAT icon
144
Caterpillar
CAT
$387B
$389K 0.02%
2,845
-10,650
-79% -$1.41M
NVDA icon
145
NVIDIA
NVDA
$4.77T
$381K 0.02%
91,640
-1,152,120
-93% -$4.77M
GILD icon
146
Gilead Sciences
GILD
$167B
$373K 0.02%
5,495
-12,384
-69% -$815K
HON icon
147
CALL
Honeywell
HON
$78.3B
$354K 0.02%
+2,122
New +$338K
ADBE icon
148
Adobe
ADBE
$99B
$336K 0.02%
1,114
-2,760
-71% -$767K
PFE icon
149
Pfizer
PFE
$144B
$327K 0.02%
7,863
-97,199
-93% -$3.86M
IBM icon
150
CALL
IBM
IBM
$214B
$322K 0.02%
+2,406
New +$316K

Similar funds

Gladius Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Gladius Capital Management held 183 positions worth $1.68B, down 7.3% from $1.81B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Gladius Capital Management withdrew a net $223M in Q2 2019, closing 16 positions and reducing 95 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $1.31M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 2.3% of assets, down from 2.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Gladius Capital Management opened a new position in SPDR Gold Trust worth $40.8M.

  • Gladius Capital Management's largest Q2 2019 buy was SPDR Gold Trust: 312,170 shares worth $40.8M.
  • Gladius Capital Management added most to Walt Disney in Q2 2019, an estimated $19.6M increase.
  • Gladius Capital Management's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $12.4M.
  • Gladius Capital Management fully exited Walgreens Boots Alliance in Q2 2019, selling an estimated $1.31M.
  • Gladius Capital Management's ten largest holdings make up 66% of its $1.68B portfolio in Q2 2019.
  • Gladius Capital Management opened 57 new positions and closed 16 in Q2 2019.
  • Gladius Capital Management's portfolio value fell 7.3% quarter-over-quarter to $1.68B.

Based on Gladius Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.